TipRanks
Tiziana Life Sciences Plc (TLSA)
NASDAQ:TLSA
US Market
TLSA
Tiziana Life Sciences
RESEARCH TOOLSreports

Tiziana Life Sciences (TLSA) Stock News & Sentiment

706 Followers
Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy
Premium
Company Announcements
Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy
14d ago
6K
TLSA
Tiziana Life Sciences Doses First Participants in Phase 2a ALS BANYAN Trial of Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Doses First Participants in Phase 2a ALS BANYAN Trial of Intranasal Foralumab
16d ago
6K
TLSA
Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained
22d ago
TLSA
Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
Premium
Company Announcements
Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
23d ago
6K
TLSA
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
Premium
Company Announcements
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
27d ago
6K
TLSA
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
Premium
Company Announcements
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
2M ago
6K
TLSA
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
Premium
TipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
2M ago
IMUX
QNTM
More TLSA News >

TLSA News on the Web

Tiziana Life Sciences announces last patient completed Phase 2a INFORM-MS trial
TipRanks News
Bullish
Biotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind
rttnews
Bullish
Tiziana Life Sciences signs MOU with KAIMRC in Saudi Arabia
TipRanks News
Bullish
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
TipRanks News
Bullish
Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration
Proactive Investors
Bullish
Tiziana Life Sciences initiated with a Buy at BTIG
TipRanks News
Bullish
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
TipRanks News
Bullish
Tiziana Life Sciences CEO Makes Bold Insider Move Signaling Growing Confidence
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average3.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TLSA’s Media Buzz Sentiment?
Currently, no data Available
What is TLSA’s weekly average amount of articles?
In an average week, 3.75 articles about TLSA are published.
    What is TLSA’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GKOSGlaukos
    RYTMRhythm Pharmaceuticals
    DHRDanaher
    HALOHalozyme
    VRTXVertex Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week